No black box warning on record for Ubrelvy

As of the latest FDA labeling reviewed, Ubrelvy (UBROGEPANT) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ubrelvy medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: If a serious hypersensitivity reaction occurs, discontinue UBRELVY and initiate appropriate therapy. Severe hypersensitivity reactions have included anaphylaxis and dyspnea. These reactions can occur within minutes, hours, or days after administration. ( 5.1 ) Hypertension: New-onset or worsening of pre-existing hypertension may occur. ( 5.2 )

No black box warning on record for Ubrelvy

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: If a serious hypersensitivity reaction occurs, discontinue UBRELVY and initiate appropriate therapy. Severe hypersensitivity reactions have included anaphylaxis and dyspnea. These reactions can occur within minutes, hours, or days after administration. ( 5.1 ) Hypertension: New-onset or worsening of pre-existing hypertension may occur. ( 5.2 )

Ubrelvy Black Box Warning

No black box warning on record for Ubrelvy

Other warnings & precautions

Ubrelvy Black Box Warning

No black box warning on record for Ubrelvy

Other warnings & precautions